[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations68614095
h-index2822
i10-index20599

..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE

..
:: Volume 32, Issue 5 (12-2024) ::
Journal of Ilam University of Medical Sciences 2024, 32(5): 14-22 Back to browse issues page
Investigating the relationship between coagulation indices and mortality in patients with COVID-19 hospitalized in the intensive care unit of Dezful Ganjavian hospital in 2020
Mahin Behzadifard * 1, Zahra Eslamifar2 , Yasin Arianezhad3 , Nooshin Asadmasjedi2 , Behnam Azizolahi2 , Maziyar Heydari4
1- Dept of Laboratory Sciences, Faculty of Paramedicine, Dezful University of Medical Sciences, Dezful, Iran , mahinbehzadi2020@gmail.com
2- Dept of Laboratory Sciences, Faculty of Paramedicine, Dezful University of Medical Sciences, Dezful, Iran
3- Student Research Committee of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4- Student Research Committee, Dezful University of Medical Sciences, Dezful, Iran
Abstract:   (153 Views)
Introduction:  Many factors, including coagulation disorders, have an effect on mortality in patients with Covid-19 viral infection. Considering coagulation problems are so important for these patients, the goal of this study was to look into the connection between coagulation test results, such as prothrombin time (PT), partial thromboplastin time (PTT), D-dimer, and platelet count, and the death rate in Covid-19 patients who were admitted to the intensive care unit of Ganjovian Hospital (Dezful, Iran) in 2020.
Materials & Methods: This comprehensive cross-sectional study was conducted on the information of 100 patients with Covid-19 hospitalized in the intensive care unit. The data from the patient’s files were analyzed using Graph Pad Prism version 8.3 statistical software. Qualitative variables were described using frequency indices, percentages, and relative frequency. A t-test was also used to compare the study parameters between the death and discharge groups. The level of significance was considered less than 0.05.
Results: The mean and standard deviation of the age were 58.2±14.2. The average age of the death group was significantly higher than that of discharged patients (P=0.038). The D-dimer and PT test results in patients with Covid-19 who died were significantly higher than those of discharged patients (P=0.002), but there was no significant difference in platelet count and PTT between the two groups (P=0.680).
Conclusion: According to the results of this study, paying attention to the results of D-dimer and PT tests may be helpful in predicting the prognosis of Covid-19 disease.
 
Keywords: Covid-19, SARS-CoV-2, nSARS-CoV-2, D-dimer, Prothrombin time, Relative thromboplastin time, Platelet count, Intensive care unit, ICU
Full-Text [PDF 722 kb]   (96 Downloads)    
Type of Study: Research | Subject: virology
Received: 2024/04/13 | Accepted: 2024/05/21 | Published: 2024/12/5
References
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi : 10.1016/S0140-6736(20)30183-5.
2. Ceraolo C, Giorgi FM. Genomic variance of the 2019-nCoV coronavirus. J Med Viro 2020;92:522-8. doi: 10.1002/jmv.25700.
3. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7. doi: 10.1002/path.1570.
4. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol 2020;5:529-30. doi: 10.1016/S2468-1253(20)30084-4.
5. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020;413:116832. doi: 10.1016/j.jns.2020.116832.
6. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020;98:219-27. doi: 10.1016/j.kint.2020.04.003.
7. Hadifar S, Moghoofei M, Nematollahi S, Ramazanzadeh R, Sedighi M, Salehi-Abargouei A, et al. Epidemiology of Multidrug Resistant Uropathogenic Escherichia coli in Iran: a Systematic Review and Meta-Analysis. Jpn J Infect Dis 2017;70:19-25. doi: 10.7883/yoken.JJID.2015.652.
8. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020;10:537-40. doi: 10.1542/hpeds.2020-0123.
9. Harahsheh AS, Dahdah N, Newburger JW, Portman MA, Piram M, Tulloh R, et al. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J Pediatr 2020;222:261-2. doi: 10.1016/j.jpeds.2020.04.052.
10. Rivera-Figueroa EI, Santos R, Simpson S, Garg P. Incomplete Kawasaki Disease in a Child with Covid-19. Indian Pediatr 2020;57:680-1. doi: 10.1007/s13312-020-1900-0.
11. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934-43. doi: 10.1001/jamainternmed.2020.0994.
12. Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020;58:1116-20. doi: 10.1515/cclm-2020-0188.
13. Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res 2020;190:62. doi: 10.1016/j.thromres.2020.04.014.
14. Connell NT, Battinelli EM, Connors JM. Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost 2020;18:E1-e2. doi: 10.1111/jth.14893.
15. Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi 2020; 49:411-17. Chinese. ‌ doi: 10.3760/cma.j.cn112151-20200312-00193.
16. Choi G, Schultz MJ, van Till JW, Bresser P, van der Zee JS, Boermeester MA, et al. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 2004;24:786-9. doi: 10.1183/09031936.04.00140703.
17. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-2. doi: 10.1016/S2213-2600(20)30076-X.
18. Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol 2020;2:e255-e6. doi: 10.1016/S2665-9913(20)30092-8.
19. Li Z, Yin M, Zhang H, Ni W, Pierce RW, Zhou HJ, et al. BMX represses thrombin-PAR1–mediated endothelial permeability and vascular leakage during early sepsis. Circ Res 2020;126:471-85. doi: 10.1161/CIRCRESAHA.119.315769.
20. Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol 2020;214:108393. doi: 10.1016/j.clim.2020.108393.
21. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417-8. doi: 10.1016/S0140-6736(20)30937-5.
22. Perdomo J, Leung HHL, Ahmadi Z, Yan F, Chong JJH, Passam FH, et al. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun 2019;10:1322. doi: 10.1038/s41467-019-09160-7.
23. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020;136:489-500. doi: 10.1182/blood.2020006520.
24. He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep 2021;11:1830. doi: 10.1038/s41598-021-81300-w.
25. Zhang X, Liu ZQ, Zhang W, Xu Q. A retrospective analysis of plasma D-dimer dynamic variation in terminal stage cancer patients: implications for disease progression. Int J Clinl Exp Med 2014;7:2395-401.
26. Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care 2020;24:1-8. doi: 10.1186/s13054-020-03077-0.
27. Gandhi A, Görlinger K. Coagulopathy in COVID-19: Connecting the dots together. J Card Crit Care TSS 2020;4:47-50. doi:10.1055/s-0040-1712739.
28. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemos 2020;18:844-7. doi: 10.1111/jth.14768.
29. Zhuang Q, Zeng Y, Shi Y. Coagulopathy correlates with outcomes in patients with community- acquired pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2014;37:406-10.
30. Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020;95:834-47. doi: 10.1002/ajh.25829.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.DUMS.REC.1399.072


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Behzadifard M, Eslamifar Z, Arianezhad Y, Asadmasjedi N, Azizolahi B, Heydari M. Investigating the relationship between coagulation indices and mortality in patients with COVID-19 hospitalized in the intensive care unit of Dezful Ganjavian hospital in 2020. J. Ilam Uni. Med. Sci. 2024; 32 (5) :14-22
URL: http://sjimu.medilam.ac.ir/article-1-8261-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 32, Issue 5 (12-2024) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 1.04 seconds with 41 queries by YEKTAWEB 4671